Engineered nucleic acid-targeting nucleic acids
US-11505808-B2 · Nov 22, 2022 · US
This page is not indexed by search engines while we improve data quality.
Caribou Biosciences Inc patents in 2022
Caribou Biosciences Inc was listed as an assignee on 11 patent publications in 2022.
| Metric | Value |
|---|---|
| Company | Caribou Biosciences Inc |
| Year | 2022 |
| Patents | 11 |
Patents
Representative publications for Caribou Biosciences Inc in 2022.
Crispr abasic restricted nucleotides and crispr accuracy via analogs
US-2022348929-A1 · Nov 3, 2022 · US
Humanized BCMA antibody and BCMA-CAR-T cells
US-11472884-B2 · Oct 18, 2022 · US
Methods of use of CRISPR CPF1 hybrid DNA/RNA polynucleotides
US-11459588-B2 · Oct 4, 2022 · US
Compositions and methods of nucleic acid-targeting nucleic acids
US-2022282244-A1 · Sep 8, 2022 · US
Top CPC classifications
Most common classification codes for Caribou Biosciences Inc in 2022.
| CPC | Patents |
|---|---|
| C12N2310/20 | 7 |
| A61P35/00 | 6 |
| C12N15/113 | 6 |
| C12N15/902 | 6 |
| C12N9/22 | 6 |
Related pages
Navigate to parent entity pages.